DXB vs RAD

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

37LOW

RAD

RADIOPHARM FPO [RAD]

37LOW

Score Breakdown

DXB RAD
Technical
45
38
Catalyst
56
51
Sentiment
50
50
Fundamental
82
76
Momentum
43
52
Risk Gate
50
27

Key Metrics

DXB Metric RAD
$195.1MMarket Cap$42.6M
1.2MAvg Volume (20d)4.7M
+0.1%Short Interest+0.1%
$0.78552-Week High$0.040
$0.32052-Week Low$0.017
+0.0%Daily Change+5.3%
$0.325Entry Price$0.020
-594.5%ROE-92.1%
-219.9%Profit Margin-286.2%

Active Signals

DXB Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Lagging the Small Ords index — relative strength of 0.76, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)

RAD Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.3x normal while price falls — heavy selling pressure
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●4C filed 2026-01-27
●Low P/S ratio (2.6x)
●Strong revenue growth (+154%)

Ask Scout AI to compare DXB and RAD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
DXB Full Analysis → RAD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).